Cite
HARVARD Citation
Cecil, D. et al. (2021). Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways. Journal for immunotherapy of cancer. 9 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cecil, D. et al. (2021). Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways. Journal for immunotherapy of cancer. 9 (3), p. . [Online].